Cargando…
Inhibitory of active dual cancer targeting 5-Fluorouracil nanoparticles on liver cancer in vitro and in vivo
The chitosan (CS) material as the skeleton nano-drug delivery system has the advantages of sustained release, biodegradability, and modifiability, and has broad application prospects. In the previous experiments, biotin (Bio) was grafted onto CS to synthesize biotin-modified chitosan (Bio-CS), and i...
Autores principales: | Cheng, Mingrong, Dai, Dejian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389539/ https://www.ncbi.nlm.nih.gov/pubmed/35992879 http://dx.doi.org/10.3389/fonc.2022.971475 |
Ejemplares similares
-
Synthesis of Glycyrrhetinic Acid-Modified Chitosan 5-Fluorouracil Nanoparticles and Its Inhibition of Liver Cancer Characteristics in Vitro and in Vivo
por: Cheng, Mingrong, et al.
Publicado: (2013) -
Synthesis of liver-targeting dual-ligand modified GCGA/5-FU nanoparticles and their characteristics in vitro and in vivo
por: Cheng, Mingrong, et al.
Publicado: (2013) -
Anti-cancer efficacy of biotinylated chitosan nanoparticles in liver cancer
por: Cheng, Mingrong, et al.
Publicado: (2017) -
The In-Vitro Antitumor Effects of AST-3424 Monotherapy and Combination Therapy With Oxaliplatin or 5-Fluorouracil in Primary Liver Cancer
por: Zhang, Yu, et al.
Publicado: (2022) -
In vitro and in vivo evaluation of cubosomes containing 5-fluorouracil for liver targeting
por: Nasr, Mohamed, et al.
Publicado: (2015)